Bis-ethylhexyloxyphenol methoxyphenyl triazine clinical trials
How each study uses bis-ethylhexyloxyphenol methoxyphenyl triazine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2022 (3)
| Year | Studies |
|---|---|
| 2020 | 1 |
| 2022 | 3 |
Who runs them
Industry 4 · Other 0
Studies
Open first, then newest update. How each study uses bis-ethylhexyloxyphenol methoxyphenyl triazine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Pharmacokinetic (PK) Evaluation of Bemotrizinol (6%) in a Sunscreen Maximum Usage TrialCompletedPhase 3DSM Nutritional Products, Inc.NCT05277376Written as Bemotrizinol (6%)
- Photoallergic Potential of 6% BemotrizinolCompletedPhase 2DSM Nutritional Products, Inc.NCT05254912Written as 6% Bemotrizinol in sunscreen formulation
- Phototoxicity Potential of 6% BemotrizinolCompletedPhase 2DSM Nutritional Products, Inc.NCT05254925Written as Sunscreen oil with 6% Bemotrizinol
- Bemotrizinol UV Filter Part 1 Clinical PK Evaluation in Topical MUsT StudyCompletedPhase 1DSM Nutritional Products, Inc.NCT04355286Written as Bemotrizinol
Given beside what is tested · 1 — bis-ethylhexyloxyphenol methoxyphenyl triazine is usual care or a partner of the new treatment
Codes
What other systems call bis-ethylhexyloxyphenol methoxyphenyl triazine · ClinicalTrials.gg INT004393
- MeSH (NLM) C439083bis-ethylhexyloxyphenol methoxyphenyl triazineOne source NLM
- UNII (FDA) PWZ1720CBHBEMOTRIZINOLConfirmed FDA, NLM
- RxNorm 1306115One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C439083 | bis-ethylhexyloxyphenol methoxyphenyl triazine | One source NLM |
| UNII (FDA) | PWZ1720CBH | BEMOTRIZINOL | Confirmed FDA, NLM |
| RxNorm | 1306115 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.